Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Frigo

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Endocrinology|May 8, 2023
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate CancerJavier Leo, Eleonora Dondossola, Kaitlin J Basham, et al.
Cancer Research|September 17, 2008
Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeuticAndrea B Sherk, Daniel E Frigo, Christine G Schnackenberg, et al.
Cancer Research|September 5, 2006
AKT regulation of estrogen receptor beta transcriptional activity in breast cancerBich N Duong, Steven Elliott, Daniel E Frigo, et al.
Molecular Metabolism|September 13, 2025
Myeloid-specific CAMKK2 deficiency protects against diet-induced obesity and insulin resistance by rewiring metabolic gene expression and enhancing energy expenditureAndrea R Ortiz, Kevin Nay, Brittany A Stork, et al.
Molecular Cancer Research : MCR|September 16, 2022
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate CancerFederica Mossa, Daniele Robesti, Ramachandran Sumankalai, et al.
Oncogene|February 3, 2021
Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signalingChenchu Lin, Alicia M Blessing, Thomas L Pulliam, et al.
Molecular Imaging and Biology|May 12, 2018
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In VivoNiki Zacharias, Jaehyuk Lee, Sumankalai Ramachandran, et al.
Oncotarget|August 28, 2015
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagySanchaika Gaur, Yunfei Wen, Jian H Song, et al.
Nature Communications|June 30, 2026
Divergent roles of SPOP and CHD1 in ACSL4 regulation reveal context-dependent vulnerabilities for targeting ferroptosisFeiyu Chen, Qidong Li, Qianlin Gu, et al.
International Journal of Oncology|May 13, 2004
Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signalingChristopher B Weldon, Amanda P Parker, Daniel Patten, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Endocrinology|May 8, 2023
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate CancerJavier Leo, Eleonora Dondossola, Kaitlin J Basham, et al.
Cancer Research|September 17, 2008
Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeuticAndrea B Sherk, Daniel E Frigo, Christine G Schnackenberg, et al.
Cancer Research|September 5, 2006
AKT regulation of estrogen receptor beta transcriptional activity in breast cancerBich N Duong, Steven Elliott, Daniel E Frigo, et al.
Molecular Metabolism|September 13, 2025
Myeloid-specific CAMKK2 deficiency protects against diet-induced obesity and insulin resistance by rewiring metabolic gene expression and enhancing energy expenditureAndrea R Ortiz, Kevin Nay, Brittany A Stork, et al.
Molecular Cancer Research : MCR|September 16, 2022
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate CancerFederica Mossa, Daniele Robesti, Ramachandran Sumankalai, et al.
Oncogene|February 3, 2021
Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signalingChenchu Lin, Alicia M Blessing, Thomas L Pulliam, et al.
Molecular Imaging and Biology|May 12, 2018
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In VivoNiki Zacharias, Jaehyuk Lee, Sumankalai Ramachandran, et al.
Oncotarget|August 28, 2015
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagySanchaika Gaur, Yunfei Wen, Jian H Song, et al.
Nature Communications|June 30, 2026
Divergent roles of SPOP and CHD1 in ACSL4 regulation reveal context-dependent vulnerabilities for targeting ferroptosisFeiyu Chen, Qidong Li, Qianlin Gu, et al.
International Journal of Oncology|May 13, 2004
Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signalingChristopher B Weldon, Amanda P Parker, Daniel Patten, et al.
Pageof 8